Doss-Gollin, Simon http://orcid.org/0000-0001-8797-7452
Thomas, Sanya http://orcid.org/0000-0003-3648-9461
Brook, Byron http://orcid.org/0000-0003-3184-8285
Abedi, Kimia http://orcid.org/0009-0004-8574-8217
Lebas, CĂ©lia
Auderset, Floriane
Lugo-Rodriguez, Yamile
Sanchez-Schmitz, Guzman http://orcid.org/0000-0002-3566-7505
Dowling, David J. http://orcid.org/0000-0003-1095-6156
Levy, Ofer http://orcid.org/0000-0002-5859-1945
van Haren, Simon D. http://orcid.org/0000-0002-1791-0161
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-004886)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (1U19AI168643)
Article History
Received: 23 September 2022
Accepted: 9 October 2023
First Online: 26 October 2023
Competing interests
: S.vH., B.B., D.J.D., and O.L. are named inventors on several patent applications related to vaccine adjuvants that were not included in this study. The other authors declare no conflict of interest.